Time period for reporting SAEs and other events requiring expedited reporting. All SAEs and other events as noted in Sections 10.2, and 10.3 regardless of relationship to study therapy will be reported in an expedited manner as described in Section 10.6.
Appears in 2 contracts
Sources: Clinical Trial Collaboration and Supply Agreement (Nugenerex Immuno-Oncology, Inc.), Clinical Trial Collaboration and Supply Agreement (Generex Biotechnology Corp)